Loading...
Loading...
Among the 4 tracked institutional investors we monitor, ABVC (ABVC BIOPHARMA INC) is held with a combined value of $931.41K across 489,270 shares. The largest holder is VANGUARD GROUP INC with a position worth $613.31K. CITADEL ADVISORS LLC opened a new position in the most recent quarter. 1 fund increased its holdings.
Total Institutional Value
$931.41K
Total Shares Held
489,270
Institutional Holders
4
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $613.31K | 0.00% | +7.7% |
| 2 | STATE STREET CORP | $115.02K | 0.00% | - |
| 3 | CITADEL ADVISORS LLC | $113.90K | 0.00% | New |
| 4 | BlackRock, Inc. | $89.18K | 0.00% | - |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of ABVC with a position worth $613.31K, representing 0.00% of their portfolio. In total, 4 institutional investors hold ABVC with a combined value of $931.41K.
In the most recent quarter, 1 fund opened a new position in ABVC. Additionally, 1 increased their holdings.
Institutional investors hold $931.41K worth of ABVC stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $613.31K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ABVC, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ABVC positions.
Last Close
$1.00
2026-10-21
YTD
-54.8%
12% of 52-week range